Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement
- Conditions
- Aortic Stenosis
- Registration Number
- NCT00584116
- Lead Sponsor
- University of California, Davis
- Brief Summary
Prospective, two academic center, non-randomized pilot, acute in-patient study correlating pre-operative imaging studies, intra-operative measurements and intra-operative balloon aortic valvuloplasty (BAV) in patients with degenerative aortic stenosis undergoing surgical aortic valve replacement (SAVR) to understand the requirements (device size and radial strength) of emerging percutaneous heart valve technologies in the treatment of aortic stenosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2
-
Age 18 years or older
-
Any patient with severe, symptomatic calcific aortic stenosis (AS) referred for elective surgical aortic valve replacement.
- Severe AS: aortic valve area (AVA) ≤ 1.0 cm2
- Symptoms: dyspnea on exertion, heart failure, angina or syncope believed to be secondary to AS
- Emergent surgical aortic valve replacement.
- Inability to undergo TTE or TEE intra-operatively.
- Currently participating in another study that has not completed the primary endpoint or that clinically interferes with the current study endpoints.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method aortic annulus size 2 months Show the correlation between the size of the aortic annulus measured intra-operatively with surgical rings (gold standard) with other methods of aortic annulus measurement that would not require surgical intervention (CT, TEE, TTE)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UC Davis Medical Center
🇺🇸Sacramento, California, United States